Senzar Asset Management’s Biogen BIIB Stock Holding History

Senzar Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-101,600	Closed	-$24.6M	–	39
2016 Q2	$24.6M	Buy	+101,600	New	+$26.8M	5.35%	5
2016 Q1	–	Sell	-86,300	Closed	-$26.4M	–	40
2015 Q4	$26.4M	Sell	86,300 -3,200	-4%	-$920K	2.94%	10
2015 Q3	$26.1M	Buy	+89,500	New	+$29.6M	3.8%	9
2015 Q1	–	Sell	-37,800	Closed	-$12.8M	–	35
2014 Q4	$12.8M	Buy	37,800 +11,000	+41%	+$3.56M	3.76%	7
2014 Q3	$8.87M	Buy	+26,800	New	+$8.84M	2.6%	14
2014 Q2	–	Sell	-18,200	Closed	-$5.57M	–	27
2014 Q1	$5.57M	Buy	+18,200	New	+$5.78M	2.95%	13

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Senzar Asset Management's BIIB Position: Q3 2016 in Review

Senzar Asset Management sold out of Biogen (BIIB) in Q3 2016, closing a stake of 101,600 shares — an estimated $24.6M sold.

Senzar Asset Management first reported a position in BIIB in Q1 2014 and held it in 6 quarters. The position peaked at $26.4M in Q4 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Senzar Asset Management reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
Senzar Asset Management sold 101,600 Biogen shares in Q3 2016, an estimated $24.6M.
Senzar Asset Management first reported a position in Biogen in Q1 2014 and held it in 6 quarters.
Senzar Asset Management's Biogen position peaked at $26.4M in Q4 2015.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Senzar Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.